Titre:
  • Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Auteur:D'Haens, Geert; vander Woude, Janneke; Van Hootegem, Ph; Moreau, Jacques; Louis, Edouard; Franchimont, Denis; De Vos, Martine; Mana, Fazia; Peyrin-Biroulet, Laurent; Brixi, Hedia; Allez, Matthieu; Vermeire, Séverine; Caenepeel, Philippe; Aubourg, Alexandre; Oldenburg, Bas; Pierik, Marieke; Gils, Ann; Chevret, Sylvie; Laharie, David; Détré, Patricia; Bertin, Marie Jo; Williams, Sabrina; Lambrecht, Guy; Baert, Filip; Bossuyt, Peter; Pariente, Benjamin; Buisson, Anthony; Bouhnik, Yoram; Filippi, Jerome
Informations sur la publication:Gastroenterology, 154, 5, page (1343-1351.e1)
Statut de publication:Publié, 2018-04
Sujet CREF:Gastro-entérologie
Mots-clés:Crohn's Disease
Infliximab
Mucosal Healing
Therapeutic Drug Monitoring
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0016-5085
info:doi/10.1053/j.gastro.2018.01.004
info:pii/S0016508518300155
info:scp/85044617922